Challenges to pharmaceutical policymaking: lessons from Australia’s national medicines policy | Zendy

Wendy Lipworth | Zendy; Evan Doran | Zendy; Ian Kerridge | Zendy; Richard O. Day | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Challenges to pharmaceutical policymaking: lessons from Australia’s national medicines policy

Author(s) -

Wendy Lipworth,

Evan Doran,

Ian Kerridge,

Richard O. Day

Publication year - 2014

Publication title -

australian health review

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.644

H-Index - 46

eISSN - 1449-8944

pISSN - 0156-5788

DOI - 10.1071/ah13240

Subject(s) - health economics , pharmaceutical policy , population health , public health , government (linguistics) , public administration , health policy , public policy , political science , economic growth , health care , medicine , economics , linguistics , philosophy , nursing

National medicines policies (NMP) provide a means for governments to achieve their objectives in relation to pharmaceuticals and other medicines. This research aimed to identify challenges to implementing the objectives of the Australian NMP from the perspective of key stakeholders.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research